EGF and familial pancreatic carcinoma: In patients with primary pancreatic cancer, circulating levels of VEGF (p < 0.0001) were significantly increased compared to healthy control subjects, whereas circulating levels of PDGF-AA (p < 0.0001), Ang-1 (p = 0.002) and EGF (p < 0.0001) were significantly decreased.